Leading AI labs are strategically releasing high-risk capabilities, like cybersecurity exploits, to trusted defenders before a general public release. This pattern, seen with Anthropic and OpenAI, aims to harden systems against potential misuse, with biosafety likely being the next frontier for this approach.

The argument for rapidly advancing powerful AI is that only the leading labs can influence safety protocols. This 'stay in the lead to steer' philosophy creates a paradox: to mitigate AI risk, companies feel compelled to accelerate its development, potentially amplifying the very dangers they aim to control.

Hugging Face's CEO argues that regulators' caution towards new models isn't surprising. Frontier labs spent years marketing their own models (like GPT-2) as dangerously powerful, which naturally led governments to take a more hands-on, safety-first approach to their deployment.

A pause on training new, more capable AI models could paradoxically increase risk. It would halt progress at the few, relatively safety-conscious frontier labs, allowing less scrupulous competitors to catch up. Meanwhile, compute stockpiling would continue, making any subsequent capability leap even faster and more dangerous.

Top American AI labs intentionally limit their models' capabilities in sensitive areas like cybersecurity and biology to prevent misuse. This "self-hobbling" creates a strategic vulnerability, forcing them to rely on less-restricted foreign models, like China's Kimmy, to solve complex security incidents they can no longer handle themselves.

The rhetoric around AI's existential risks is framed as a competitive tactic. Some labs used these narratives to scare investors, regulators, and potential competitors away, effectively 'pulling up the ladder' to cement their market lead under the guise of safety.

The public discourse on slowing down AI development for safety reasons may have a secondary, financial motive. Since training frontier models is the largest expense for AI labs, a collective pause or slowdown serves as a "great way to reduce costs ahead of an IPO," improving financial optics.

Anthropic's decision to gate its Mythos model, framed as a safety precaution, also creates powerful marketing hype, drives enterprise adoption of its native tools, and makes it harder for competitors to create imitator models.

The pattern is clear: from OpenAI releasing ChatGPT to the creator of OpenClaw, those who move fast and bypass safety concerns achieve massive adoption and market leads. This forces more cautious competitors into a perpetual game of catch-up.